#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type II Non-small cell lung cancer Pemphigus Pelizaeus-Merzbacher disease Urea cycle disorder Lupus nephritis Hepatitis B Neurofibromatosis Short stature homeobox gene mutation Mucopolysaccharidosis III Sarcoidosis Atypical haemolytic uraemic syndrome Anti-HLA antibody test positive Insulinoma Vernal keratoconjunctivitis More trials…

    Learn about Rare Diseases

    Breast angiosarcoma Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Lymphangioma – Diagnostics Amyotrophic lateral sclerosis – Treatment Phenylketonuria – Diagnostics Alternating hemiplegia of childhood – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Rhabdoid tumour – Life with Disease Vascular malformation – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Streptococcus Agalactiae 1,3-BUTYLENE GLYCOL Flecainide Sufentanil Citrate MZE829 Oxogluric Acid Hct116-B Triamcinolone Acetonide DAPIGLUTIDE GSK5733584 Disulfiram Risdiplam Enlicitide Chloride Dantrolene Sodium Buserelin Acetate Betamethasone Acetate Argatroban Monohydrate ABBV-CLS-628 Dermatophagoides Farinae Df1001 More therapies…

    Learn about Your Condition

    Lymphangiosarcoma Metastatic malignant melanoma Gastrectomy Inflammatory bowel disease Adenosquamous cell lung cancer Sarcoidosis Mucous membrane pemphigoid Infertility Rett syndrome Oxygen saturation Pertussis Pleomorphic leiomyosarcoma Retinoblastoma Impaired gastric emptying Glucose tolerance impaired More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sickle cell anaemia

  • Comparing morphine alone to morphine and lidocaine for pain relief in sickle cell anemia patients with vaso-occlusive crisis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Morphine Hydrochloride
    • Lidocaine Hydrochloride
    Belgium

  • Evaluating Morphine Effectiveness Based on Kidney Function in Patients with Sickle Cell Disease During Vaso-occlusive Crisis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Morphine Hydrochloride
    • Iohexol
    France

  • Study on the Safety and Effectiveness of CTX001 for Children with Severe Sickle Cell Disease Using Exagamglogene Autotemcel, Busulfan, and Plerixafor

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Exagamglogene Autotemcel
    • Plerixafor
    • Busulfan
    Germany Italy

  • Long-term Safety Study of Exagamglogene Autotemcel for Patients with Sickle Cell Disease or Transfusion-Dependent Thalassemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Thalassaemia
    Investigated Drugs:
    • Exagamglogene Autotemcel
    Belgium Germany Italy

  • Study on the Effects of Exagamglogene Autotemcel for Patients with Transfusion-Dependent Beta-Thalassemia or Severe Sickle Cell Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Thalassaemia beta
    Investigated Drugs:
    • Exagamglogene Autotemcel
    • Plerixafor
    • Busulfan
    Germany Italy

  • Study of the effectiveness of iloprost compared to a placebo for treating vaso-occlusive crises in adults with sickle cell disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • ILOPROST
    • Glucose Monohydrate
    France
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!